5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo

Cell Mol Biol Lett. 2022 Sep 30;27(1):82. doi: 10.1186/s11658-022-00381-1.

Abstract

Influenza-related acute lung injury (ALI) is a life-threatening condition that results mostly from uncontrolled replication of influenza virus (IV) and severe proinflammatory responses. The methoxy flavonoid compound 5-methoxyflavone (5-MF) is believed to have superior biological activity in the treatment of cancer. However, the effects and underlying mechanism of 5-MF on IV-mediated ALI are still unclear. Here, we showed that 5-MF significantly improved the survival of mice with lethal IV infection and ameliorated IV-mediated lung edema, lung histological changes, and inflammatory cell lung recruitment. We found that 5-MF has antiviral activity against influenza A virus (IAV), which was probably associated with increased expression of radical S-adenosyl methionine domain containing 2 (RSAD2) and suppression of endosomal acidification. Moreover, IV-infected A549 cells with 5-MF treatment markedly reduced proinflammatory mediator expression (IL-6, CXCL8, TNF-α, CXCL10, CCL2, CCL3, CCL4, GM-CSF, COX-2, and PGE2) and prevented P-IKBα, P-P65, and P-P38 activation. Interestingly, we demonstrated that 5-MF treatment could trigger activation of AMP-activated protein kinase (AMPK)α in IV-infected A549 cells, as evidenced by activation of the AMPKα downstream molecule P53. Importantly, the addition of AMPKα blocker compound C dramatically abolished 5-MF-mediated increased levels of RSAD2, the inhibitory effects on H1N1 virus-elicited endosomal acidification, and the suppression expression of proinflammatory mediators (IL-6, TNF-α, CXCL10, COX-2 and PGE2), as well as the inactivation of P-IKBα, P-P65, and P-P38 MAPK signaling pathways. Furthermore, inhibition of AMPKα abrogated the protective effects of 5-MF on H1N1 virus-mediated lung injury and excessive inflammation in vivo. Taken together, these results indicate that 5-MF alleviated IV-mediated ALI and suppressed excessive inflammatory responses through activation of AMPKα signaling.

Keywords: 5-Methoxyflavone; AMPKα; Anti-inflammatory; Antiviral; Influenza A virus.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Acute Lung Injury* / metabolism
  • Animals
  • Antiviral Agents / pharmacology
  • Cyclooxygenase 2
  • Flavones
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Granulocyte-Macrophage Colony-Stimulating Factor / metabolism
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Inflammation / drug therapy
  • Influenza A Virus, H1N1 Subtype* / metabolism
  • Influenza A virus* / metabolism
  • Interleukin-6 / metabolism
  • Methionine / pharmacology
  • Methionine / therapeutic use
  • Mice
  • NF-kappa B / metabolism
  • Prostaglandins E / pharmacology
  • Prostaglandins E / therapeutic use
  • Tumor Necrosis Factor-alpha / metabolism
  • Tumor Suppressor Protein p53
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • 5-methoxyflavone
  • Antiviral Agents
  • Flavones
  • Flavonoids
  • Interleukin-6
  • NF-kappa B
  • Prostaglandins E
  • Tumor Necrosis Factor-alpha
  • Tumor Suppressor Protein p53
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Methionine
  • Cyclooxygenase 2
  • p38 Mitogen-Activated Protein Kinases
  • AMP-Activated Protein Kinases